Candidate gene association analysis of acute lymphoblastic leukemia identifies new susceptibility locus at 11p15 (LMO1)

Carcinogenesis

Volumn 32, Issue 9, 2011, Pages 1349-1353

  Beuten, Joke ^a   Gelfond, Jonathan A L ^a   Piwkham, Duangjai ^a,b   Pollock, Brad H ^a   Winick, Naomi J ^c   Collier III, Anderson B ^c,d   Tomlinson, Gail E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABL1 PROTEIN; ATM PROTEIN; BLNK PROTEIN; BREAKPOINT CLUSTER REGION PROTEIN; CCND1 PROTEIN; CD6 ANTIGEN; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOCHROME P450 1A1; E1A ASSOCIATED P300 PROTEIN; FPGS PROTEIN; IKZF1 PROTEIN; JANUS KINASE 2; LMO1 PROTEIN; LYL1 PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; NQO1 PROTEIN; NR3C1 PROTEIN; PROTEIN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH3; PROTEIN P53; SAMSN1 PROTEIN; TOP2A PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; CANCER RISK; CHROMOSOME 11P; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 80052409831     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr091     Document Type: Article

References (29)

1. Pui,C.H. et al. (2008) Acute lymphoblastic leukaemia. Lancet, 371, 1030-1043.
2. Armstrong,S.A. et al. (2005) Molecular genetics of acute lymphoblastic leukemia. J. Clin. Oncol., 23, 6306-6315.
3. Mullighan,C.G. (2009) Genomic analysis of acute leukemia. Int. J. Lab. Hematol., 31, 384-397.
4. Brassesco,M.S. (2008) Leukemia/lymphoma-associated gene fusions in normal individuals. Genet. Mol. Res., 7, 782-790.
5. Emerenciano,M. et al. (2009) ETV6-RUNX1 fusion gene and additional genetic changes in infant leukemia: a genome-wide analysis. Cancer Genet. Cytogenet., 193, 86-92.
6. Hemminki,K. et al. (2002) Risks among siblings and twins for childhood acute lymphoid leukaemia: results from the Swedish Family-Cancer Database. Leukemia, 16, 297-298.
7. Han,S. et al. (2010) Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk. Res., 34, 1271-1274.
8. Papaemmanuil,E. et al. (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat. Genet., 41, 1006-1010.
9. Trevino,L.R. et al. (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat. Genet., 41, 1001-1005.
10. Bolufer,P. et al. (2006) Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk. Res., 30, 1471-1491.
11. Karathanasis,N.V. et al. (2009) Gene polymorphisms in childhood ALL. Pediatr. Blood Cancer, 52, 318-323.
12. Krause,D.S. et al. (2005) Tyrosine kinases as targets for cancer therapy. N. Engl. J. Med., 353, 172-187.
13. Chokkalingam,A.P. et al. (2008) Genetic susceptibility to childhood leukaemia. Radiat. Prot. Dosimetry, 132, 119-129.
14. Vijayakrishnan,J. et al. (2010) Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and metaanalysis. Haematologica, 95, 1405-1414.
15. French,B. et al. (2006) Simple estimates of haplotype relative risks in casecontrol data. Genet. Epidemiol., 30, 485-494.
16. Nyholt,D.R. (2004) A simple correction for multiple testing for singlenucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet., 74, 765-769.
17. Wang,K. et al. (2011) Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature, 469, 216-220.
18. Boehm,T. et al. (1991) The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc. Natl Acad. Sci. U S A, 88, 4367-4371.
19. Liu,X. et al. (2008) TiGER: a database for tissue-specific gene expression and regulation. BMC Bioinformatics, 9, 271.
20. Rabbitts,T.H. (1994) Chromosomal translocations in human cancer. Nature, 372, 143-149.
21. Izraeli,S. (2004) Leukaemia-a developmental perspective. Br. J. Haematol., 126, 3-10.
22. Aifantis,I. et al. (2008) Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat. Rev. Immunol., 8, 380-390.
23. Klemsz,M.J. et al. (1990) The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell, 61, 113-124.
24. Cantor,A.B. et al. (2002) Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene, 21, 3368-3376.
25. Nutt,S.L. et al. (2007) The transcriptional regulation of B cell lineage commitment. Immunity, 26, 715-725.
26. McKercher,S.R. et al. (1996) Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J., 15, 5647-5658.
27. Scott,E.W. et al. (1994) Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science, 265, 1573-1577.
28. Scheidereit,C. et al. (1988) A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein. Nature, 336, 551-557.
29. Schwarzenbach,H. et al. (1995) Involvement of the Ets family factor PU.1 in the activation of immunoglobulin promoters. J. Biol. Chem., 270, 898-907.